Arrowhead Pharmaceuticals (ARWR) Receivables - Net (2016 - 2025)
Historic Receivables - Net for Arrowhead Pharmaceuticals (ARWR) over the last 14 years, with Q4 2025 value amounting to $218.9 million.
- Arrowhead Pharmaceuticals' Receivables - Net rose 865484.0% to $218.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $218.9 million, marking a year-over-year increase of 865484.0%. This contributed to the annual value of $6.8 million for FY2025, which is N/A changed from last year.
- As of Q4 2025, Arrowhead Pharmaceuticals' Receivables - Net stood at $218.9 million, which was up 865484.0% from $6.8 million recorded in Q3 2025.
- Over the past 5 years, Arrowhead Pharmaceuticals' Receivables - Net peaked at $218.9 million during Q4 2025, and registered a low of $150000.0 during Q4 2021.
- Its 5-year average for Receivables - Net is $24.4 million, with a median of $2.4 million in 2025.
- Per our database at Business Quant, Arrowhead Pharmaceuticals' Receivables - Net plummeted by 9833.37% in 2021 and then surged by 2627866.67% in 2022.
- Over the past 5 years, Arrowhead Pharmaceuticals' Receivables - Net (Quarter) stood at $150000.0 in 2021, then skyrocketed by 26278.67% to $39.6 million in 2022, then plummeted by 96.11% to $1.5 million in 2023, then skyrocketed by 62.44% to $2.5 million in 2024, then skyrocketed by 8654.84% to $218.9 million in 2025.
- Its Receivables - Net stands at $218.9 million for Q4 2025, versus $6.8 million for Q3 2025 and $9.7 million for Q2 2025.